Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.59, Iss.5, 2000-05, pp. : 1137-1147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemifloxacin: a new fluoroquinolone
By Blondeau Joseph M Missaghi Bayan
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. :
Access to resources
Recommend
Gemifloxacin: A Viewpoint by Lionel A. Mandell
By Mandell L.A.
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
Gemifloxacin offers advantages over clarithromycin for AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Gemifloxacin: Factive, LB 20304, SB 265805
Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. :
Gemifloxacin offers advantages over clarithromycin for AECB
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :